FASENRA® (benralizumab) is a prescription medication for patients with severe asthma 12 years of age or older, with an eosinophilic phenotype.
Please refer to the full prescribing information.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.